T. Rowe Price Investment Management’s Alignment Healthcare ALHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $173M | Buy |
12,331,720
+3,253,607
| +36% | +$45.6M | 0.11% | 198 |
|
|
2025
Q1 | $169M | Buy |
9,078,113
+429,071
| +5% | +$7.99M | 0.11% | 193 |
|
|
2024
Q4 | $97.3M | Buy |
8,649,042
+3,059,596
| +55% | +$34.4M | 0.06% | 300 |
|
|
2024
Q3 | $66.1M | Sell |
5,589,446
-2,443,795
| -30% | -$28.9M | 0.04% | 366 |
|
|
2024
Q2 | $62.8M | Sell |
8,033,241
-270,901
| -3% | -$2.12M | 0.04% | 362 |
|
|
2024
Q1 | $41.2M | Sell |
8,304,142
-3,771,362
| -31% | -$18.7M | 0.03% | 423 |
|
|
2023
Q4 | $104M | Buy |
12,075,504
+682,602
| +6% | +$5.88M | 0.07% | 269 |
|
|
2023
Q3 | $79.1M | Sell |
11,392,902
-183,774
| -2% | -$1.28M | 0.06% | 290 |
|
|
2023
Q2 | $66.6M | Buy |
11,576,676
+934,653
| +9% | +$5.37M | 0.05% | 327 |
|
|
2023
Q1 | $67.7M | Buy |
10,642,023
+2,171,842
| +26% | +$13.8M | 0.05% | 325 |
|
|
2022
Q4 | $99.6M | Buy |
8,470,181
+1,108,973
| +15% | +$13M | 0.08% | 262 |
|
|
2022
Q3 | $87.2M | Buy |
+7,361,208
| New | +$87.2M | 0.07% | 267 |
|